- Home
- BLTE vs MLKN Comparison
BLTE vs MLKN Comparison
Compare BLTE & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- MLKN
- Stock Information
- Founded
- BLTE 2018
- MLKN 1905
- Country
- BLTE United States
- MLKN United States
- Employees
- BLTE N/A
- MLKN N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- MLKN Office Equipment/Supplies/Services
- Sector
- BLTE Health Care
- MLKN Consumer Discretionary
- Exchange
- BLTE Nasdaq
- MLKN Nasdaq
- Market Cap
- BLTE 2.1B
- MLKN 1.8B
- IPO Year
- BLTE 2022
- MLKN N/A
- Fundamental
- Price
- BLTE $64.12
- MLKN $22.55
- Analyst Decision
- BLTE Strong Buy
- MLKN
- Analyst Count
- BLTE 4
- MLKN 0
- Target Price
- BLTE $89.00
- MLKN N/A
- AVG Volume (30 Days)
- BLTE 62.6K
- MLKN 1.1M
- Earning Date
- BLTE 11-12-2024
- MLKN 12-18-2024
- Dividend Yield
- BLTE N/A
- MLKN 3.35%
- EPS Growth
- BLTE N/A
- MLKN 36.64
- EPS
- BLTE N/A
- MLKN 0.91
- Revenue
- BLTE N/A
- MLKN $3,593,100,000.00
- Revenue This Year
- BLTE N/A
- MLKN $4.04
- Revenue Next Year
- BLTE N/A
- MLKN $4.16
- P/E Ratio
- BLTE N/A
- MLKN $24.71
- Revenue Growth
- BLTE N/A
- MLKN N/A
- 52 Week Low
- BLTE $31.01
- MLKN $20.89
- 52 Week High
- BLTE $86.53
- MLKN $31.73
- Technical
- Relative Strength Index (RSI)
- BLTE 44.50
- MLKN 34.56
- Support Level
- BLTE $60.00
- MLKN $20.89
- Resistance Level
- BLTE $76.87
- MLKN $25.72
- Average True Range (ATR)
- BLTE 4.51
- MLKN 0.87
- MACD
- BLTE -0.44
- MLKN -0.29
- Stochastic Oscillator
- BLTE 24.42
- MLKN 35.05
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.